- Stocks
- Healthcare
- NYSE: ZBH

Price (delayed)

$178.45

Market cap

$37.09B

P/E Ratio

N/A

Dividend/share

$0.96

EPS

-$0.67

Enterprise value

$44.42B

Zimmer Biomet is a publicly traded medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of

ZBH's equity is up by 2.7% since the previous quarter

The EPS has plunged by 112% YoY but it has grown by 8% from the previous quarter

The net income has dropped by 112% year-on-year but it has grown by 9% since the previous quarter

Zimmer Biomet Holdings's gross profit has decreased by 15% YoY and by 2.1% from the previous quarter

The revenue has contracted by 12% YoY

What are the main financial stats of ZBH

Market
Valuations
Earnings

Shares outstanding

207.86M

Market cap

$37.09B

Enterprise value

$44.42B

Price to earnings (P/E)

N/A

Price to book (P/B)

3.03

Price to sales (P/S)

5.26

EV/EBIT

N/A

EV/EBITDA

45.85

EV/Sales

6.32

Revenue

$7.02B

EBIT

-$63.9M

EBITDA

$968.8M

Free cash flow

$794.9M

Per share
Balance sheet
Liquidity

EPS

-$0.67

Free cash flow per share

$3.84

Book value per share

$58.83

Revenue per share

$33.93

TBVPS

$39.13

Total assets

$24.42B

Total liabilities

$12.22B

Debt

$8.13B

Equity

$12.19B

Working capital

$2.53B

Debt to equity

0.67

Current ratio

1.99

Quick ratio

0.88

Net debt/EBITDA

7.56

Margins
Efficiency
Dividend

EBITDA margin

13.8%

Gross margin

69.7%

Net margin

-2%

Operating margin

-1.2%

Return on assets

-0.6%

Return on equity

-1.2%

Return on invested capital

-0.5%

Return on capital employed

-0.3%

Return on sales

-0.9%

Dividend yield

0.54%

DPS

$0.96

Payout ratio

N/A

How has the Zimmer Biomet Holdings stock price performed over time

Intraday

0.6%

1 week

3.82%

1 month

14.29%

1 year

57.93%

YTD

15.81%

QTD

11.48%

How have Zimmer Biomet Holdings's revenue and profit performed over time

Revenue

$7.02B

Gross profit

$4.9B

Operating income

-$87.8M

Net income

-$138.9M

Gross margin

69.7%

Net margin

-2%

The net margin has dropped by 114% year-on-year but it has increased by 9% since the previous quarter

The net income has dropped by 112% year-on-year but it has grown by 9% since the previous quarter

Zimmer Biomet Holdings's operating income has shrunk by 108% YoY

Zimmer Biomet Holdings's operating margin has shrunk by 108% YoY

What is Zimmer Biomet Holdings's growth rate over time

What is Zimmer Biomet Holdings stock price valuation

P/E

N/A

P/B

3.03

P/S

5.26

EV/EBIT

N/A

EV/EBITDA

45.85

EV/Sales

6.32

The EPS has plunged by 112% YoY but it has grown by 8% from the previous quarter

The stock's P/B is 37% above its 5-year quarterly average of 2.2 and 37% above its last 4 quarters average of 2.2

ZBH's equity is up by 2.7% since the previous quarter

ZBH's price to sales (P/S) is 58% higher than its 5-year quarterly average of 3.3 and 41% higher than its last 4 quarters average of 3.7

The revenue has contracted by 12% YoY

How efficient is Zimmer Biomet Holdings business performance

Zimmer Biomet Holdings's return on equity has shrunk by 113% YoY but it has increased by 8% QoQ

The ROA has plunged by 113% YoY

The ROS has plunged by 106% YoY

The ROIC has shrunk by 105% YoY

What is ZBH's dividend history

DPS

$0.96

Dividend yield

0.54%

Payout ratio

N/A

Recent dividends

How did Zimmer Biomet Holdings financials performed over time

The total assets is 100% higher than the total liabilities

ZBH's quick ratio has soared by 52% YoY but it is down by 14% QoQ

The current ratio has grown by 45% YoY but it has contracted by 12% from the previous quarter

The debt is 33% smaller than the equity

The debt to equity has declined by 4.3% since the previous quarter

ZBH's equity is up by 2.7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.